Menu

Forecasting New Pharma Products – Improving accuracy

Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always end up prescribing these new medications as much as they initially plan or as early as they would like. There are many reasons that can explain this discrepancy – with the most common ones pertaining to coverage/reimbursement issues or the drug efficacy and safety features not exactly aligning with physicians’ initial expectations or the amount of time that elapses between a new product launch and the time physicians become fully familiar with it. This can often make forecasting physicians’ likelihood of prescribing new medications challenging for pharmaceutical manufacturers. See our latest infographic to learn more about the factors impacting early adoption rates.

Read More

Over the years, MD Analytics has supported the launch of a large number of new products for its healthcare and pharmaceutical clients, across a broad spectrum of indications ranging from lifestyle drugs to oncology treatments. We have regularly observed physicians’ significant enthusiasm for new products based on unbranded descriptions, as well as the large anticipated shares of prescriptions they provide for them.

While it has been difficult for our clients to gauge the extent to which physicians overstate their likely prescribing of a new product, we have been able to leverage our large database of such products to more accurately assess the extent of this overstatement and improve the accuracy in forecasting for new pharma products. This additional level of precision can make the difference when gauging the resources needed to put behind a new product launch and to more precisely plan the levels of production required for the new treatment.

If you are curious to see if our Share Gap Algorithm would be a good fit for the launch of your new product, learn more here.

Past Quick Polls

Remote detailing for pharma – Physicians’ perspectives – Canada

Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.

read more

Does Online Advertising Click for Physicians?

Strong online advertising and messaging are key to maximizing impact of any marketing campaign. With recent restrictions on in-person interactions, online advertising and messaging play an even greater role in reaching physicians. Our findings from a survey of n=227 Canadian physicians show that 82% of Canadian physicians have increased their use of online platforms as a result of COVID-19, 48% significantly so.

read more

Physicians’ Perspectives on Cannabis Legalization – One year later

In October 2018, the use of recreational cannabis was legalized across Canada. Looking back at the past year, physicians remain divided in their views towards this new legislation, though support skews towards younger GPs. This legislation has impacted the use of prescription treatments and patient visits in a number of key therapeutic areas, though not to the degree that was anticipated 12 months ago.

read more

We are here to answer your questions.

Topical Polls and Industry Trends

Virtual Medical Conferences – Promoting your brand to a digital audience

Virtual Medical Conferences – Promoting your brand to a digital audience

Virtual medical conferences are on the rise, but are they here to stay?

As a result of the pandemic over the past year, conference organizers and medical brands were set scrambling to find a solution to limit cancelations of key medical conferences. Resulting virtual platforms advanced quickly to emulate the face-to-face conference experience through a digital means. While many virtual medical conferences were successful, in terms of strong participation levels to many key events both national and international, questions remained as to how well they met the needs of physicians, other healthcare providers and the pharmaceutical and medical device companies sponsoring these events.

read more
Remote detailing for pharma – Physicians’ perspectives – U.S.

Remote detailing for pharma – Physicians’ perspectives – U.S.

The detailing of healthcare providers through virtual means has become a staple for pharmaceutical brands and is essential for any go-to-market strategy. When face-to-face detailing was put on hold this past year, healthcare providers began experiencing an even greater volume of requests for virtual interactions. For pharma brand teams, ensuring your approach to digital communications matches with the preferences of providers is important in helping your messages get through to your target prescribers.

In our latest quick poll, conducted in March 2021, MD Analytics sought to gain clarity around current remote detailing preferences and identify the components of an “ideal” remote interaction.

read more
The Future of Medical Conferences is Virtual – U.S.

The Future of Medical Conferences is Virtual – U.S.

Each year, providers and health industry professionals travel from locations around the world to share and discuss the latest developments in medical care. For several years now, conferences have been experimenting with digital features that allow participants to engage remotely, avoiding the burdens of travel. However, the scope of content available to digital participants had often been limited and physician adoption was low.

read more

Your answers,
our guarantee.

Your answers,
our guarantee.

We are here to answer your questions.

Latest Survey Data

Virtual Medical Conferences – Promoting your brand to a digital audience

Virtual Medical Conferences – Promoting your brand to a digital audience

Virtual medical conferences are on the rise, but are they here to stay?

As a result of the pandemic over the past year, conference organizers and medical brands were set scrambling to find a solution to limit cancelations of key medical conferences. Resulting virtual platforms advanced quickly to emulate the face-to-face conference experience through a digital means. While many virtual medical conferences were successful, in terms of strong participation levels to many key events both national and international, questions remained as to how well they met the needs of physicians, other healthcare providers and the pharmaceutical and medical device companies sponsoring these events.

read more
Remote detailing for pharma – Physicians’ perspectives – Canada

Remote detailing for pharma – Physicians’ perspectives – Canada

Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.

read more

Members of the Canadian Research Insights Council (CRIC) and the Insights Association.

Share This